APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunity Support Ingredients

As the spread of COVID-19 outside China increased, consumers are interested in immunization. With the search for ways to strengthen the immune system, activities in this field are booming, especially vitamin C. In the past few months, the demand for immunity support products increased dramatically.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

As the spread of COVID-19 outside China increased, consumers are interested in immunization. With the search for ways to strengthen the immune system, activities in this field are booming, especially vitamin C. In the past few months, the demand for immunity support products increased dramatically.

Selected research

Market Outlook & Growth Opportunities

Global Immunity Support Ingredients Market Outlook and Growth Opportunities 2026

30 December 2025217 pages

Choose your research edition.

Industry ResearchImmunity Support Ingredients Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunity Support Ingredients Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Immunity Support Ingredients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunity Support Ingredients Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunity Support Ingredients Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

As the spread of COVID-19 outside China increased, consumers are interested in immunization. With the search for ways to strengthen the immune system, activities in this field are booming, especially vitamin C. In the past few months, the demand for immunity support products increased dramatically.

From the perspective of manufacturers, the main global players of support innovations are DSM, BASF, Cargill, Kerry, Kemin, Croda, Zhejiang NHU, Chr. Hansen, Shandong Luwei, CSPC Pharma, Allied Biotech, Zhengjiang Medicine, Dohler, etc. In 2019, the global top five players are DSM, BASF, Zhejiang NHU, Croda and CSPC Pharma, with 44.78% market share of revenue. Among them, DSM is the largest manufacturers of Immunity Support Ingredients.DSM occupied about 23% of the global Immunity Support Ingredients market.

This report provides an overview of the global Immunity Support Ingredients market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Immunity Support Ingredients and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immunity Support Ingredients revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Immunity Support Ingredients market.

Immunity Support Ingredients Segment by Company

DSM

BASF

Zhejiang NHU

Croda

CSPC Pharma

EPAX

Adisseo

Zhejiang Medicine

Raisio Group

Northeast Pharma

Shandong Luwei

Allied Biotech

Cargill

Anhui Tiger

Shandong Tianli

Kerry

Dohler

Kemin

Chenguang Biotech

FMC

Chr. Hansen

Excelvite

DDW

Immunity Support Ingredients Segment by Type

Vitamin C

Vitamin E

Other Vitamins

Beta Glucans

Carotenoids

Phytosterols

Omega-3 Fatty Acids

Immunity Support Ingredients Segment by Application

Nutrition Supplements

Foods & Beverages

Pharmaceuticals

Feeds

Pet Foods

Personal Care Products

Immunity Support Ingredients Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Immunity Support Ingredients status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Immunity Support Ingredients key companies, revenue, market share, and recent developments.

3. To split the Immunity Support Ingredients breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Immunity Support Ingredients market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Immunity Support Ingredients significant trends, drivers, influence factors in global and regions.

6. To analyze Immunity Support Ingredients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunity Support Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunity Support Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunity Support Ingredients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immunity Support Ingredients industry.

Chapter 3: Detailed analysis of Immunity Support Ingredients company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Immunity Support Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Immunity Support Ingredients in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Immunity Support Ingredients Industry Trends Table 2. Immunity Support Ingredients Industry Drivers Table 3. Immunity Support Ingredients Industry Opportunities and Challenges Table 4. Immunity Support Ingredients Industry Restraints Table 5. Global Immunity Support Ingredients Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Immunity Support Ingredients Revenue Share by Company (2021-2026) Table 7. Global Immunity Support Ingredients Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Immunity Support Ingredients Key Company Manufacturing Base & Headquarters Table 9. Global Immunity Support Ingredients Company, Product Type & Application Table 10. Global Immunity Support Ingredients Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Immunity Support Ingredients by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Vitamin C Table 15. Significant Companies of Vitamin E Table 16. Significant Companies of Other Vitamins Table 17. Significant Companies of Beta Glucans Table 18. Significant Companies of Carotenoids Table 19. Significant Companies of Phytosterols Table 20. Significant Companies of Omega-3 Fatty Acids Table 21. Global Immunity Support Ingredients Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 22. Global Immunity Support Ingredients Sales Value by Type (2021-2026) & (US$ Million) Table 23. Global Immunity Support Ingredients Sales Value by Type (2027-2032) & (US$ Million) Table 24. Global Immunity Support Ingredients Sales Value Share by Type (2021-2026) Table 25. Global Immunity Support Ingredients Sales Value Share by Type (2027-2032) Table 26. Significant Companies of Nutrition Supplements Table 27. Significant Companies of Foods & Beverages Table 28. Significant Companies of Pharmaceuticals Table 29. Significant Companies of Feeds Table 30. Significant Companies of Pet Foods Table 31. Significant Companies of Personal Care Products Table 32. Global Immunity Support Ingredients Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Immunity Support Ingredients Sales Value by Application (2021-2026) & (US$ Million) Table 34. Global Immunity Support Ingredients Sales Value by Application (2027-2032) & (US$ Million) Table 35. Global Immunity Support Ingredients Sales Value Share by Application (2021-2026) Table 36. Global Immunity Support Ingredients Sales Value Share by Application (2027-2032) Table 37. Global Immunity Support Ingredients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Immunity Support Ingredients Sales Value by Region (2021-2026) & (US$ Million) Table 39. Global Immunity Support Ingredients Sales Value Share by Region (2021-2026) Table 40. Global Immunity Support Ingredients Sales Value by Region (2027-2032) & (US$ Million) Table 41. Global Immunity Support Ingredients Sales Value Share by Region (2027-2032) Table 42. Global Immunity Support Ingredients Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Immunity Support Ingredients Sales Value by Country (2021-2026) & (US$ Million) Table 44. Global Immunity Support Ingredients Sales Value Market Share by Country (2021-2026) Table 45. Global Immunity Support Ingredients Sales Value by Country (2027-2032) & (US$ Million) Table 46. Global Immunity Support Ingredients Sales Value Market Share by Country (2027-2032) Table 47. DSM Company Information Table 48. DSM Business Overview Table 49. DSM Immunity Support Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. DSM Immunity Support Ingredients Product Portfolio Table 51. DSM Recent Development Table 52. BASF Company Information Table 53. BASF Business Overview Table 54. BASF Immunity Support Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. BASF Immunity Support Ingredients Product Portfolio Table 56. BASF Recent Development Table 57. Zhejiang NHU Company Information Table 58. Zhejiang NHU Business Overview Table 59. Zhejiang NHU Immunity Support Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Zhejiang NHU Immunity Support Ingredients Product Portfolio Table 61. Zhejiang NHU Recent Development Table 62. Croda Company Information Table 63. Croda Business Overview Table 64. Croda Immunity Support Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Croda Immunity Support Ingredients Product Portfolio Table 66. Croda Recent Development Table 67. CSPC Pharma Company Information Table 68. CSPC Pharma Business Overview Table 69. CSPC Pharma Immunity Support Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. CSPC Pharma Immunity Support Ingredients Product Portfolio Table 71. CSPC Pharma Recent Development Table 72. EPAX Company Information Table 73. EPAX Business Overview Table 74. EPAX Immunity Support Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. EPAX Immunity Support Ingredients Product Portfolio Table 76. EPAX Recent Development Table 77. Adisseo Company Information Table 78. Adisseo Business Overview Table 79. Adisseo Immunity Support Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Adisseo Immunity Support Ingredients Product Portfolio Table 81. Adisseo Recent Development Table 82. Zhejiang Medicine Company Information Table 83. Zhejiang Medicine Business Overview Table 84. Zhejiang Medicine Immunity Support Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Zhejiang Medicine Immunity Support Ingredients Product Portfolio Table 86. Zhejiang Medicine Recent Development Table 87. Raisio Group Company Information Table 88. Raisio Group Business Overview Table 89. Raisio Group Immunity Support Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Raisio Group Immunity Support Ingredients Product Portfolio Table 91. Raisio Group Recent Development Table 92. Northeast Pharma Company Information Table 93. Northeast Pharma Business Overview Table 94. Northeast Pharma Immunity Support Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Northeast Pharma Immunity Support Ingredients Product Portfolio Table 96. Northeast Pharma Recent Development Table 97. Shandong Luwei Company Information Table 98. Shandong Luwei Business Overview Table 99. Shandong Luwei Immunity Support Ingredients Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Shandong Luwei Immunity Support Ingredients Product Portfolio Table 101. Shandong Luwei Recent Development Table 102. Allied Biotech Company Information Table 103. Allied Biotech Business Overview Table 104. Allied Biotech Immunity Support Ingredients Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Allied Biotech Immunity Support Ingredients Product Portfolio Table 106. Allied Biotech Recent Development Table 107. Cargill Company Information Table 108. Cargill Business Overview Table 109. Cargill Immunity Support Ingredients Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Cargill Immunity Support Ingredients Product Portfolio Table 111. Cargill Recent Development Table 112. Anhui Tiger Company Information Table 113. Anhui Tiger Business Overview Table 114. Anhui Tiger Immunity Support Ingredients Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Anhui Tiger Immunity Support Ingredients Product Portfolio Table 116. Anhui Tiger Recent Development Table 117. Shandong Tianli Company Information Table 118. Shandong Tianli Business Overview Table 119. Shandong Tianli Immunity Support Ingredients Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Shandong Tianli Immunity Support Ingredients Product Portfolio Table 121. Shandong Tianli Recent Development Table 122. Kerry Company Information Table 123. Kerry Business Overview Table 124. Kerry Immunity Support Ingredients Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Kerry Immunity Support Ingredients Product Portfolio Table 126. Kerry Recent Development Table 127. Dohler Company Information Table 128. Dohler Business Overview Table 129. Dohler Immunity Support Ingredients Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Dohler Immunity Support Ingredients Product Portfolio Table 131. Dohler Recent Development Table 132. Kemin Company Information Table 133. Kemin Business Overview Table 134. Kemin Immunity Support Ingredients Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Kemin Immunity Support Ingredients Product Portfolio Table 136. Kemin Recent Development Table 137. Chenguang Biotech Company Information Table 138. Chenguang Biotech Business Overview Table 139. Chenguang Biotech Immunity Support Ingredients Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Chenguang Biotech Immunity Support Ingredients Product Portfolio Table 141. Chenguang Biotech Recent Development Table 142. FMC Company Information Table 143. FMC Business Overview Table 144. FMC Immunity Support Ingredients Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. FMC Immunity Support Ingredients Product Portfolio Table 146. FMC Recent Development Table 147. Chr. Hansen Company Information Table 148. Chr. Hansen Business Overview Table 149. Chr. Hansen Immunity Support Ingredients Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Chr. Hansen Immunity Support Ingredients Product Portfolio Table 151. Chr. Hansen Recent Development Table 152. Excelvite Company Information Table 153. Excelvite Business Overview Table 154. Excelvite Immunity Support Ingredients Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Excelvite Immunity Support Ingredients Product Portfolio Table 156. Excelvite Recent Development Table 157. DDW Company Information Table 158. DDW Business Overview Table 159. DDW Immunity Support Ingredients Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. DDW Immunity Support Ingredients Product Portfolio Table 161. DDW Recent Development Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Immunity Support Ingredients Product Image Figure 2. Global Immunity Support Ingredients Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunity Support Ingredients Market Size (2021-2032) & (US$ Million) Figure 4. Global Immunity Support Ingredients Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Vitamin C Image Figure 8. Vitamin E Image Figure 9. Other Vitamins Image Figure 10. Beta Glucans Image Figure 11. Carotenoids Image Figure 12. Phytosterols Image Figure 13. Omega-3 Fatty Acids Image Figure 14. Global Immunity Support Ingredients Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Immunity Support Ingredients Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Immunity Support Ingredients Sales Value Share by Type (2021-2032) Figure 17. Nutrition Supplements Image Figure 18. Foods & Beverages Image Figure 19. Pharmaceuticals Image Figure 20. Feeds Image Figure 21. Pet Foods Image Figure 22. Personal Care Products Image Figure 23. Global Immunity Support Ingredients Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Immunity Support Ingredients Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Immunity Support Ingredients Sales Value Share by Application (2021-2032) Figure 26. Global Immunity Support Ingredients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 27. Global Immunity Support Ingredients Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 28. North America Immunity Support Ingredients Sales Value (2021-2032) & (US$ Million) Figure 29. North America Immunity Support Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Europe Immunity Support Ingredients Sales Value (2021-2032) & (US$ Million) Figure 31. Europe Immunity Support Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Asia-Pacific Immunity Support Ingredients Sales Value (2021-2032) & (US$ Million) Figure 33. Asia-Pacific Immunity Support Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 34. South America Immunity Support Ingredients Sales Value (2021-2032) & (US$ Million) Figure 35. South America Immunity Support Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Middle East & Africa Immunity Support Ingredients Sales Value (2021-2032) & (US$ Million) Figure 37. Middle East & Africa Immunity Support Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 38. USA Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. USA Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. USA Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Canada Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Canada Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Canada Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Mexico Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Mexico Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Mexico Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Germany Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Germany Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Germany Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. France Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. France Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. France Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. U.K. Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. U.K. Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. U.K. Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Italy Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Italy Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Italy Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Spain Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Spain Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Spain Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Russia Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Russia Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Russia Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Netherlands Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Netherlands Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Netherlands Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Nordic Countries Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Nordic Countries Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Nordic Countries Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. China Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. China Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. China Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Japan Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Japan Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Japan Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. South Korea Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. South Korea Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. South Korea Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. India Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. India Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. India Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Australia Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Australia Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Australia Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Southeast Asia Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Southeast Asia Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Southeast Asia Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Brazil Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Brazil Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Brazil Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Argentina Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Argentina Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Argentina Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Chile Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Chile Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Chile Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Colombia Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Colombia Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Colombia Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Peru Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Peru Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Peru Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Saudi Arabia Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Saudi Arabia Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Israel Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Israel Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Israel Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. UAE Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. UAE Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. UAE Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Turkey Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Turkey Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Turkey Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Iran Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Iran Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Iran Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Egypt Immunity Support Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Egypt Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Egypt Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Years Considered Figure 123. Research Process Figure 124. Key Executives Interviewed

Scope & coverage.

Types
  • Vitamin C
  • Vitamin E
  • Other Vitamins
  • Beta Glucans
  • Carotenoids
  • Phytosterols
  • Omega-3 Fatty Acids
Applications
  • Nutrition Supplements
  • Foods & Beverages
  • Pharmaceuticals
  • Feeds
  • Pet Foods
  • Personal Care Products
Companies covered
  • DSM
  • BASF
  • Zhejiang NHU
  • Croda
  • CSPC Pharma
  • EPAX
  • Adisseo
  • Zhejiang Medicine
  • Raisio Group
  • Northeast Pharma
  • Shandong Luwei
  • Allied Biotech
  • Cargill
  • Anhui Tiger
  • Shandong Tianli
  • Kerry
  • Dohler
  • Kemin
  • Chenguang Biotech
  • FMC
  • Chr. Hansen
  • Excelvite
  • DDW

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Immunity Support Ingredients Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Immunity Support Ingredients Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Immunity Support Ingredients Market Dynamics
  1. 2.1 Immunity Support Ingredients Industry Trends
  2. 2.2 Immunity Support Ingredients Industry Drivers
  3. 2.3 Immunity Support Ingredients Industry Opportunities and Challenges
  4. 2.4 Immunity Support Ingredients Industry Restraints
3 Immunity Support Ingredients Market by Company
  1. 3.1 Global Immunity Support Ingredients Company Revenue Ranking in 2025
  2. 3.2 Global Immunity Support Ingredients Revenue by Company (2021-2026)
  3. 3.3 Global Immunity Support Ingredients Company Ranking (2024-2026)
  4. 3.4 Global Immunity Support Ingredients Company Manufacturing Base and Headquarters
  5. 3.5 Global Immunity Support Ingredients Company Product Type and Application
  6. 3.6 Global Immunity Support Ingredients Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Immunity Support Ingredients Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Immunity Support Ingredients Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Immunity Support Ingredients Market by Type
  1. 4.1 Immunity Support Ingredients Type Introduction
  2. 4.1.1 Vitamin C
  3. 4.1.2 Vitamin E
  4. 4.1.3 Other Vitamins
  5. 4.1.4 Beta Glucans
  6. 4.1.5 Carotenoids
  7. 4.1.6 Phytosterols
  8. 4.1.7 Omega-3 Fatty Acids
  9. 4.2 Global Immunity Support Ingredients Sales Value by Type
  10. 4.2.1 Global Immunity Support Ingredients Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Immunity Support Ingredients Sales Value by Type (2021-2032)
  12. 4.2.3 Global Immunity Support Ingredients Sales Value Share by Type (2021-2032)
5 Immunity Support Ingredients Market by Application
  1. 5.1 Immunity Support Ingredients Application Introduction
  2. 5.1.1 Nutrition Supplements
  3. 5.1.2 Foods & Beverages
  4. 5.1.3 Pharmaceuticals
  5. 5.1.4 Feeds
  6. 5.1.5 Pet Foods
  7. 5.1.6 Personal Care Products
  8. 5.2 Global Immunity Support Ingredients Sales Value by Application
  9. 5.2.1 Global Immunity Support Ingredients Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Immunity Support Ingredients Sales Value by Application (2021-2032)
  11. 5.2.3 Global Immunity Support Ingredients Sales Value Share by Application (2021-2032)
6 Immunity Support Ingredients Regional Value Analysis
  1. 6.1 Global Immunity Support Ingredients Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immunity Support Ingredients Sales Value by Region (2021-2032)
  3. 6.2.1 Global Immunity Support Ingredients Sales Value by Region: 2021-2026
  4. 6.2.2 Global Immunity Support Ingredients Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Immunity Support Ingredients Sales Value (2021-2032)
  7. 6.3.2 North America Immunity Support Ingredients Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Immunity Support Ingredients Sales Value (2021-2032)
  10. 6.4.2 Europe Immunity Support Ingredients Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Immunity Support Ingredients Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Immunity Support Ingredients Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Immunity Support Ingredients Sales Value (2021-2032)
  16. 6.6.2 South America Immunity Support Ingredients Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Immunity Support Ingredients Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Immunity Support Ingredients Sales Value Share by Country, 2025 VS 2032
7 Immunity Support Ingredients Country-level Value Analysis
  1. 7.1 Global Immunity Support Ingredients Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Immunity Support Ingredients Sales Value by Country (2021-2032)
  3. 7.2.1 Global Immunity Support Ingredients Sales Value by Country (2021-2026)
  4. 7.2.2 Global Immunity Support Ingredients Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Immunity Support Ingredients Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Immunity Support Ingredients Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Immunity Support Ingredients Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DSM
  2. 8.1.1 DSM Company Information
  3. 8.1.2 DSM Business Overview
  4. 8.1.3 DSM Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  5. 8.1.4 DSM Immunity Support Ingredients Product Portfolio
  6. 8.1.5 DSM Recent Developments
  7. 8.2 BASF
  8. 8.2.1 BASF Company Information
  9. 8.2.2 BASF Business Overview
  10. 8.2.3 BASF Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BASF Immunity Support Ingredients Product Portfolio
  12. 8.2.5 BASF Recent Developments
  13. 8.3 Zhejiang NHU
  14. 8.3.1 Zhejiang NHU Company Information
  15. 8.3.2 Zhejiang NHU Business Overview
  16. 8.3.3 Zhejiang NHU Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zhejiang NHU Immunity Support Ingredients Product Portfolio
  18. 8.3.5 Zhejiang NHU Recent Developments
  19. 8.4 Croda
  20. 8.4.1 Croda Company Information
  21. 8.4.2 Croda Business Overview
  22. 8.4.3 Croda Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Croda Immunity Support Ingredients Product Portfolio
  24. 8.4.5 Croda Recent Developments
  25. 8.5 CSPC Pharma
  26. 8.5.1 CSPC Pharma Company Information
  27. 8.5.2 CSPC Pharma Business Overview
  28. 8.5.3 CSPC Pharma Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CSPC Pharma Immunity Support Ingredients Product Portfolio
  30. 8.5.5 CSPC Pharma Recent Developments
  31. 8.6 EPAX
  32. 8.6.1 EPAX Company Information
  33. 8.6.2 EPAX Business Overview
  34. 8.6.3 EPAX Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  35. 8.6.4 EPAX Immunity Support Ingredients Product Portfolio
  36. 8.6.5 EPAX Recent Developments
  37. 8.7 Adisseo
  38. 8.7.1 Adisseo Company Information
  39. 8.7.2 Adisseo Business Overview
  40. 8.7.3 Adisseo Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Adisseo Immunity Support Ingredients Product Portfolio
  42. 8.7.5 Adisseo Recent Developments
  43. 8.8 Zhejiang Medicine
  44. 8.8.1 Zhejiang Medicine Company Information
  45. 8.8.2 Zhejiang Medicine Business Overview
  46. 8.8.3 Zhejiang Medicine Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zhejiang Medicine Immunity Support Ingredients Product Portfolio
  48. 8.8.5 Zhejiang Medicine Recent Developments
  49. 8.9 Raisio Group
  50. 8.9.1 Raisio Group Company Information
  51. 8.9.2 Raisio Group Business Overview
  52. 8.9.3 Raisio Group Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Raisio Group Immunity Support Ingredients Product Portfolio
  54. 8.9.5 Raisio Group Recent Developments
  55. 8.10 Northeast Pharma
  56. 8.10.1 Northeast Pharma Company Information
  57. 8.10.2 Northeast Pharma Business Overview
  58. 8.10.3 Northeast Pharma Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Northeast Pharma Immunity Support Ingredients Product Portfolio
  60. 8.10.5 Northeast Pharma Recent Developments
  61. 8.11 Shandong Luwei
  62. 8.11.1 Shandong Luwei Company Information
  63. 8.11.2 Shandong Luwei Business Overview
  64. 8.11.3 Shandong Luwei Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shandong Luwei Immunity Support Ingredients Product Portfolio
  66. 8.11.5 Shandong Luwei Recent Developments
  67. 8.12 Allied Biotech
  68. 8.12.1 Allied Biotech Company Information
  69. 8.12.2 Allied Biotech Business Overview
  70. 8.12.3 Allied Biotech Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Allied Biotech Immunity Support Ingredients Product Portfolio
  72. 8.12.5 Allied Biotech Recent Developments
  73. 8.13 Cargill
  74. 8.13.1 Cargill Company Information
  75. 8.13.2 Cargill Business Overview
  76. 8.13.3 Cargill Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cargill Immunity Support Ingredients Product Portfolio
  78. 8.13.5 Cargill Recent Developments
  79. 8.14 Anhui Tiger
  80. 8.14.1 Anhui Tiger Company Information
  81. 8.14.2 Anhui Tiger Business Overview
  82. 8.14.3 Anhui Tiger Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Anhui Tiger Immunity Support Ingredients Product Portfolio
  84. 8.14.5 Anhui Tiger Recent Developments
  85. 8.15 Shandong Tianli
  86. 8.15.1 Shandong Tianli Company Information
  87. 8.15.2 Shandong Tianli Business Overview
  88. 8.15.3 Shandong Tianli Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Shandong Tianli Immunity Support Ingredients Product Portfolio
  90. 8.15.5 Shandong Tianli Recent Developments
  91. 8.16 Kerry
  92. 8.16.1 Kerry Company Information
  93. 8.16.2 Kerry Business Overview
  94. 8.16.3 Kerry Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Kerry Immunity Support Ingredients Product Portfolio
  96. 8.16.5 Kerry Recent Developments
  97. 8.17 Dohler
  98. 8.17.1 Dohler Company Information
  99. 8.17.2 Dohler Business Overview
  100. 8.17.3 Dohler Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Dohler Immunity Support Ingredients Product Portfolio
  102. 8.17.5 Dohler Recent Developments
  103. 8.18 Kemin
  104. 8.18.1 Kemin Company Information
  105. 8.18.2 Kemin Business Overview
  106. 8.18.3 Kemin Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Kemin Immunity Support Ingredients Product Portfolio
  108. 8.18.5 Kemin Recent Developments
  109. 8.19 Chenguang Biotech
  110. 8.19.1 Chenguang Biotech Company Information
  111. 8.19.2 Chenguang Biotech Business Overview
  112. 8.19.3 Chenguang Biotech Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Chenguang Biotech Immunity Support Ingredients Product Portfolio
  114. 8.19.5 Chenguang Biotech Recent Developments
  115. 8.20 FMC
  116. 8.20.1 FMC Company Information
  117. 8.20.2 FMC Business Overview
  118. 8.20.3 FMC Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  119. 8.20.4 FMC Immunity Support Ingredients Product Portfolio
  120. 8.20.5 FMC Recent Developments
  121. 8.21 Chr. Hansen
  122. 8.21.1 Chr. Hansen Company Information
  123. 8.21.2 Chr. Hansen Business Overview
  124. 8.21.3 Chr. Hansen Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Chr. Hansen Immunity Support Ingredients Product Portfolio
  126. 8.21.5 Chr. Hansen Recent Developments
  127. 8.22 Excelvite
  128. 8.22.1 Excelvite Company Information
  129. 8.22.2 Excelvite Business Overview
  130. 8.22.3 Excelvite Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Excelvite Immunity Support Ingredients Product Portfolio
  132. 8.22.5 Excelvite Recent Developments
  133. 8.23 DDW
  134. 8.23.1 DDW Company Information
  135. 8.23.2 DDW Business Overview
  136. 8.23.3 DDW Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  137. 8.23.4 DDW Immunity Support Ingredients Product Portfolio
  138. 8.23.5 DDW Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst